Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • EBV AND HHV-6 CIRCULATING SUBTYPES IN PEOPLE LIVING WITH HIV IN BURKINA FASO, IMPACT ON CD4 T CELL COUNT AND HIV VIRAL LOAD

    Lassina TRAORE, Ouéogo NIKIEMA, Abdoul Karim OUATTARA, Tegwindé Rébéca COMPAORE, Serge Théophile SOUBEIGA, Birama DIARRA, Dorcas OBIRI-YEBOAH, Pegdwendé Abel SORGHO, Florencia Wendkuuni DJIGMA, Cyrille BISSEYE, Albert Théophane YONLI, Jacques SIMPORE
    e2017049
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.049
    3294
    PDF: 1265
    HTML: 899
  • Kikuchi-Fujimoto Disease in the United States: Three Case Reports and Review of the Literature

    Darcie M Deaver, Mojdeh Naghashpour, Lubomir Sokol
    e2014001
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.001
    1753
    PDF: 834
    HTML: 3613
  • Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation.

    Cristina Mauro, Livio Pupo, Lucia Cardillo, Fabiana Esposito, Elisa Buzzatti, Marco Lombardo, Massimo Cesareo, Adriano Venditti, Massimiliano Postorino, Maria Ilaria Del Principi
    e2026009
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.009
    562
    PDF: 446
    Html: 294
  • HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY

    Ferhat Arslan
    e2018047
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.047
    1580
    PDF: 904
    HTML: 224
    Figure 1: 171
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    2782
    PDF: 1828
    HTML: 3668
    Pellagatti Fig 1: 214
    Pellagatti Fig. 2: 212
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    423
    PDF: 342
    HTML: 73
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4312
    PDF: 1483
    HTML: 3621
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3489
    PDF: 1579
    HTML: 7804
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3069
    PDF: 878
    HTML: 7164
    Kost Fig1: 184
    Kost Fig 2: 180
    Kost Fig3: 177
    Kost Fig 4: 191
    Kost Fig5: 186
    Kost fig 6: 174
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1372
    PDF: 758
    HTML: 942
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1669
    PDF: 647
    HTML: 2433
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2455
    PDF: 786
    HTML: 1736
  • ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

    chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi
    e2019066
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.066
    1383
    PDF: 888
    HTML: 1824
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    1002
    PDF: 630
    HTML: 2213
  • THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

    Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso
    e2023064
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.064
    1350
    PDF: 831
    HTML: 135
  • MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

    Emrah Kiliacaslan, Kadir Canoglu
    e2023003
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.003
    1441
    PDF: 1116
    HTML: 473
  • Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

    Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri
    e2022042
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.042
    879
    PDF: 416
    HTML: 200
  • Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

    Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
    e2010035
    2010-12-13
    https://doi.org/10.4084/mjhid.2010.035
    946
    PDF: 574
    HTML: 2195
    Cover Letter: 191
  • Fournier's Gangrene Complicating Hematologic Malignancies: Literature Review and Treatment Suggestions

    Giovanni D'Arena, Giuseppe Pietrantuono, Emilio Buccino, Giancarlo Pacifico, Pellegrino Musto
    e2013067
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.067
    1578
    PDF: 848
    HTML: 187060
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5266
    PDF: 1921
    HTML: 1360
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

    Fabienne McClanahan, Peter Dreger
    e2012071
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.071
    2440
    PDF: 811
    HTML: 1674
  • GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

    Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa
    e2021067
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.067
    1318
    PDF: 614
    HTML: 242
  • NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria

    Jonathan Braue, Vagishwari Murugesan, Steven Holland, Nishit Patel, Eknath Naik, Jennifer Leiding, Abraham Tareq Yacoub, Carlos N Prieto-Granada, John Norman Greene
    e2015010
    2014-12-27
    https://doi.org/10.4084/mjhid.2015.010
    1710
    PDF: 1100
    HTML: 10697
    Untitled: 189
  • Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

    Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger
    e2012034
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.034
    1214
    PDF: 1013
    HTML: 3405
  • MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

    Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh
    e2025032
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.032
    841
    PDF: 755
    HTML: 125
  • Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

    Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano
    e2026001
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.001
    663
    PDF: 481
    Html: 79
  • CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED

    Umberto Basile
    e2017007
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.007
    3972
    PDF: 1301
    HTML: 2262
  • Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

    Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola
    e2026059
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.059
    0
    PDF: 0
    HTML: 0
  • Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

    Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello
    e2025043
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.043
    1173
    PDF: 959
    HTML: 148
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1022
    PDF: 985
    HTML: 155
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1067
    PDF: 361
    Html: 111
  • Defining invasive fungal infection risk in hematological malignancies: a new tool for clinical practice

    Benedetta Rambaldi, Domenico Russo, Livio Pagano
    e2017012
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.012
    2663
    PDF: 1201
    HTML: 1566
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1493
    PDF: 1150
    HTML: 277
  • PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

    Richard A. Larson, Michelle Le Beau
    e2011032
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.032
    2829
    PDF: 918
    HTML: 1872
  • A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

    Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci
    e2023012
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.012
    891
    PDF: 945
    HTML: 414
  • Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature

    Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni
    e2023028
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.028
    988
    PDF: 763
    HTML: 343
  • Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

    Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile
    e2023061
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.061
    802
    PDF: 415
    HTML: 117
  • IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti
    e2016057
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.057
    4339
    PDF: 1111
    HTML: 1426
  • Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?

    Vincenzo Savini, Prassede Salutari, Marco Sborgia
    e2011006
    2011-01-17
    https://doi.org/10.4084/mjhid.2011.006
    1404
    PDF: 815
    HTML: 8661
    Fig 3 Savini: 172
    Fig 2 Savini: 179
    Fig 1 Savini Chest TC: 186
    Author letter to referees: 188
  • REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE

    Emmanuel Gyan, François Dreyfus, Pierre Fenaux
    e2015018
    2015-02-13
    https://doi.org/10.4084/mjhid.2015.018
    12349
    PDF: 1681
    HTML: 4198
    Cover letter: 200
    Figure 1: 204
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2276
    PDF: 1011
    HTML: 2077
  • A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

    Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo
    e2025033
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.033
    878
    PDF: 706
    HTML: 185
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1086
    PDF: 844
    HTML: 240
  • The diagnostic pitfalls of mucormycosis

    Margherita Mauro, Giuliana Lo Cascio, Rita Balter, Ada Zaccaron, Elisa Bonetti, Virgina Vitale, Matteo Chinello, Massimiliano De Bortoli, Paolo Brazzarola, Costanza Bruno, Simone Cesaro
    e2020079
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.079
    925
    PDF: 717
    HTML: 251
  • AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

    Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Peter C. Huijgens
    e2013018
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.018
    2335
    PDF: 824
    HTML: 3274
  • REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio
    e2012053
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.053
    2330
    PDF: 989
    HTML: 7624
    Untitled: 277
    Fig2: 184
    Fig3: 169
    Fig4: 181
  • DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY

    John Norman Greene, Abraham Tareq Yacoub, Dani Thomas, Carol Yuan, Frank Walsh, David Solomon, Skai Schwartz, Arthur Andrews
    e2015002
    2014-12-19
    https://doi.org/10.4084/mjhid.2015.002
    1970
    PDF: 822
    HTML: 2200
    Table 1: 178
    Table 2: 198
    Table 3: 192
    Table 4: 194
    Table 5: 190
    Tble 6: 182
    Cover Letter: 204
    Greene Tab.7: 193
  • ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

    Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos
    e2011053
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.053
    2839
    PDF: 881
    HTML: 3567
  • ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY

    Tekin Aksu
    e2018045
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.045
    2775
    PDF: 1261
    HTML: 594
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1898
    PDF: 1013
    HTML: 1348
151 - 200 of 422 items << < 1 2 3 4 5 6 7 8 9 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy